November 1, 1986Annals of Internal Medicine

Intravenous Propafenone for Termination of Reentrant Supraventricular Tachycardia

View Full Paper

Ask AI

Bookmark

Why the study?

Does intravenous propafenone safely and effectively terminate inducible sustained reentrant supraventricular tachycardia?

Population

20 patients with inducible sustained supraventricular tachycardia

Comparison

Intravenous propafenone, 2 mg/kg body weight vs Placebo

Design

RCT, Randomized, crossover study, Double-blind

Authors

ESEdward ShenSt Vincent's Hospital Sydney EKEdmund C. KeungNational University of Singapore EHEdward C. HuyckeSan Francisco General Hospital

Discussion

Member takes

Implication

May support IV propafenone for acute reentrant SVT termination; confirms efficacy in this RCT.

Structured PICO

Does intravenous propafenone safely and effectively terminate inducible sustained reentrant supraventricular tachycardia?

Population

20 patients with inducible sustained supraventricular tachycardia (3 with intra-atrial reentrant tachycardia, 3 with atrioventricular nodal reentrant tachycardia, and 14 with atrioventricular reciprocating tachycardia associated with Wolff-Parkinson-White syndrome)

Intervention

Intravenous propafenone, 2 mg/kg body weight

Comparator

Placebo

Outcome

Termination of supraventricular tachycardiahard clinical

Intravenous propafenone is highly effective and safe for the acute termination of various forms of reentrant supraventricular tachycardia.

Cite This Study

Shen et al. (1986) studied this question.

synapsesocial.com/papers/6a817949176d2ce03166286a https://doi.org/10.7326/0003-4819-105-5-655

View Full Paper

Ask AI

Bookmark

Intravenous Propafenone for Termination of Reentrant Supraventricular Tachycardia

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Intravenous Propafenone for Termination of Reentrant Supraventricular Tachycardia

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider